CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −80 | $527.49 | $42K | 24,696 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,620 | $529.04 | $1.4M | 22,076 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −577 | $530.64 | $306K | 21,499 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −587 | $531.49 | $312K | 20,912 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −288 | $532.59 | $153K | 20,624 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −642 | $533.60 | $343K | 19,982 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −506 | $534.60 | $271K | 19,476 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −440 | $535.34 | $236K | 19,036 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −160 | $536.28 | $86K | 18,876 |
| 2026-03-23 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 152,500 | ||
| 2026-03-23 | Olian Judy D. Director | Sale 10b5-1 | −200 | $530.00 | $106K | 4,245 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $518.39 | $124K | 49,773 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −906 | $519.29 | $470K | 48,867 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −867 | $520.54 | $451K | 48,000 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,320 | $521.38 | $688K | 46,680 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $522.19 | $84K | 46,520 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −647 | $524.15 | $339K | 45,873 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $525.43 | $210K | 45,473 |
| 2026-03-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −640 | $526.59 | $337K | 44,833 |
Page 142 of 171 · 3,408 trades